Ticker Details
Amarin Corporation plc Amarin Corp PLC is a biopharmaceutical company with expertise in lipid science. The company is engaged in commercialization and development of therapeutics to improve cardiovascular health.
IPO Date:	April 1, 1993
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$322.49M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.16 | 3.47%
Avg Daily Range (30 D):	$0.38 | 2.57%
Avg Daily Range (90 D):	$0.34 | 2.08%

Institutional Daily Volume
Avg Daily Volume:	2.71M
Avg Daily Volume (30 D):	.09M
Avg Daily Volume (90 D):	.09M

Trade Size
Avg Trade Size (Sh.):	303
Avg Trade Size (Sh.) (30 D):	81
Avg Trade Size (Sh.) (90 D):	78

Institutional Trades
Total Institutional Trades:	4,736
Avg Institutional Trade:	$1.26M
Avg Institutional Trade (30 D):	$.64M
Avg Institutional Trade (90 D):	$.91M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$1.48M
Avg Closing Trade (30 D):	$1.18M
Avg Closing Trade (90 D):	$1.18M
Avg Closing Volume:	6.75K

News

Nov 11, 2025 @ 7:27 PM RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE ... Source: Recordati S.P.A.

Nov 9, 2025 @ 9:15 PM New REDUCE-IT® Aspirin Analysis Presented at AH... Source: Amarin Corporation

Oct 14, 2025 @ 12:00 PM Amarin and HLS Therapeutics Collaborate on Present... Source: Amarin Corporation

Mar 12, 2025 @ 11:01 AM Amarin Announces Plan to Initiate a Ratio Change U... Source: Amarin Corporation Plc

Dec 13, 2024 @ 2:00 PM Amarin Appoints Peter Fishman Chief Financial Offi... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.21	$-.02	$-.03
Diluted EPS	$-.21	$-.02	$-.03
Revenue	$226.73M	$49.67M	$72.74M
Gross Profit	$88.13M	$22.21M	$50.36M
Net Income / Loss	$-86.19M	$-7.74M	$-14.14M
Operating Income / Loss	$-96.37M	$-11.1M	$-15.99M
Cost of Revenue	$138.6M	$27.46M	$22.38M
Net Cash Flow	$-34.37M	$-25.07M	$28.35M
PE Ratio

Splits
Apr 11, 2025	1:20
Jan 18, 2008	1:10